Member Info for driftking27

...Just looking at charts and that's what they show. Anyhows, I wasn't speaking to you.. Sales are CONTINUING to decline this year, just as earnings outlook stated. DYOR. P.S. I own AZN, GSK, JNJ and NVS (ADR) shares. 4250p aint that far away from current level of 4427p, like 5%.

I would tread water very carefully and make sure you understand what may transpire over the next couple of days/weeks from here on in Spikeyj..! If you want dividends, try HSD that has a juicey 9% dividend. But remember this; The escalating confrontation between the new Greek government and the eurozone over the terms of Greece’s bailout could lead to extreme volatility in financial markets. Therefore we would like to let you know about some key events and dates, to assist in any preparations you might decide to make. Please note that announcements could be made when the markets are closed. You may wish to reduce or hedge your market exposure in advance of any potentially significant events, or deposit additional funds onto your account to provide extra cover for your positions. Key events and dates •The new Greek government wishes to replace the current bailout programme with a new financing arrangement. Other eurozone states will need to agree to this. •A Eurogroup meeting of eurozone finance ministers on 16 February broke down after the parties were unable to reach a compromise. Another Eurogroup meeting may be held on 20 February. •The Emergency Liquidity Assistance (ELA) programme administered by the ECB for Greek banks is due to be reviewed on Wednesday 18 February (result unknown at the time of writing). •The current Greek bailout programme expires on Saturday 28 February. If there isn’t any agreement on an extension or new terms before this date, the Greek state may be unable to raise any new funds required. This could seriously impact Greece’s membership of the eurozone.

4100-4300 looks like an area we could see appear after ex-div.

You certainly have over the short-medium term. We have ex-dividend date approaching at what point it will drop 125p maybe more.. Anyway, good lucky...

Would it be that shareprice is drifting away due to earnings drifting away and dividend yield going up. Looks obvious to me! The current yield is just silly and should be cut by 1/3 to at least 6-7%.

http://www.bidnessetc.com/34374-pfizer-inc-is-not-done-with-acquisition-deals-yet/ PFizer will be doing more bolt-on deals, but AZN isn't going to be one of em... Believe me...

... I predict that it won't happen for two reasons; 1 being tax, seconf being that they have just made a big buy of Hospira in US ( worth $17bn). Though, I could be wrong!

See more downside than upside with earnings here... This is not the place to tell people to sell and move elsewhere. Sorry. You have to do your own research. What I can say is I own around 30 stocks, so I'm well diversified, and this low oil price will probably help airlines. Maybe I'd side with moving your stock to GSK as its the one that has a better growth prospect. AZN is overvalued at 18.5times earnings to GSK which I believe is 14 times earnings. You always use this as a measure. You try and buy stocks just below the FTSE average and sell once they outperform the FTSE100, plus you are getting a better dividend with GSK. GSK would be valued at over 2000p if it was in line with competitors NVS, JNJ, SNY, BMY, MRK. At present as I have just posted Pfizer has made a purchase on Hospira a US pharma valued at $17bn, from its $33bn cash pile. I can't see any future bid coming, thus the present premium that is being paid for AZN stock has to be due a re-rating downwards to below 4000p.

...Looking like 178.1p full year dividend payout with 125p + 53.8p = £1.788 is full year payout for last financial year. I will be selling up here, filling out self-assessment tax return, and reinvesting in ...more HSBC and Rolls Royce.

Oops, I was typing too fast to notice you stated $ Not £. This could drop below 4000p after the news of PFE drips through.. So I believe.

PFE agrees to buy HOSPIRA have agreed deal worth $17bn. Hospira have range of products was complementary to their own. PFE up 2.5%. Drew57 Dividend is not the same as last time, as its in $, and the £ Has strengthen loads over the last 1emths against aload of baskets of currencies... The £ is now $1.50 - £1 to around $1.60 to £1 last full years payout. http://tools.morningstar.co.uk/uk/stockreport/default.aspx?SecurityToken=0P00007NYP]3]0]E0WWE$$ALL Astrazeneca's website http://www.astrazeneca.com/Investors/Shareholder-information/Dividends Not quite sure where you magically get £1.90? Current div has been 3.8%...! You do the maths again mate.

Sorry, meant 1200p target set on BHP Billiton

In a dream world, be good if brokers were banned from releasing target prices for stocks! Then DB release some stockprice movements for Rolls Royce & BHP. Theyv set a 1200p 12mth target on Rolls, and 800p on Rolls. Though that's only 14%, 16.5% drop respectively, so could happen over a couple of weeks...

Had look back at Earnings per share in 2011 to 2014(pending). 2011 results showed $7.80 to $2.04 In 2013 and what looks like a similar fig in 2014... http://www.4-traders.com/ASTRAZENECA-PLC-4000930/financials/

Resistance I see is at 4780p; support 4410p. These are areas to look at to make sells or buys, where I will be adding more, though 3780p on a LONG is more enticing... We will see.

Just had a look back over the last months comments on this board and see one post has been removed by LSE ( think it was by Sidknee ? ). The median target over brokers is around 4900-4950p not 5600p. Remember where earnings have gone, and what Astra have at present. Further, they will be paying more now than ever on R&D so this will be eating to earnings over this year as well until we get serious about a lift in earnings. http://finance.yahoo.com/q/ao?s=AZN+Analyst+Opinion

...And no its not Astra, but Novartis. http://www.fool.com/investing/general/2015/01/24/this-stock-could-become-the-next-johnson-johnson.aspx

Just thought I post some news on one of GSK competitors Novartis this morning. Profits down http://m.benzinga.com/article/5180114

Answers to that will be announced at results 5th FEB, and as we all know, no pharma company, and ESPECIALLY Astra has raised last quarter divi, or AZN case semi annually. There profits will be significantly down, don't need to be a scientist to work that out. Research for this can be found at www.morningstar.co.uk and search AZN. You get a break down on everything there...

Agree with you BARINGSBANK. $ strength will continue to weigh on commodities, and more so with the Iranians saying they could easily tolerate $25 a barrel of oil. That will be a bloody kick in the teeth if that transpires. More job losses, and more rigs cancelled for #BHP (already cut exposure in oil by 40%). Just my thoughts... Atb I hold RIO, BHP miners along with 30 other stocks & funds/trusts. Trusts range from MYI, MUT, STOS, TEM, AST